Cell of Origin Subtype Determined by Immunohistochemistry and MYC and BCL2 Dual Expression in DLBCL as Potential Prognostic Indicators

被引：0
|
作者：
Collie, A. M. B. [1 ]
Hill, B. T. [1 ]
Hsi, E. D. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1360
引用
收藏
页码：325A / 326A
页数：2
相关论文
共 50 条
  • [31] Algorithm for Assessment and Prognostic Significance of MYC and BCL2 Expression and Rearrangements in Diffuse Large B-cell Lymphoma (DLBCL) - All Wales Lymphoma Panel Study
    Pugh, M. R.
    Joshi, A.
    Attanoos, R. L.
    Dojcinov, S. D.
    JOURNAL OF PATHOLOGY, 2016, 240 : 13 - 13
  • [32] Prognostic Understanding in Newly Diagnosed Older Adults with Diffuse Large B Cell Lymphoma (DLBCL) or DLBCL/High Grade B-Cell Lymphoma with MYC and BCL2 rearrangements
    Markovitz, Netana
    Odejide, Oreofe O.
    El-Jawahri, Areej
    Johnson, Patrick Connor
    BLOOD, 2023, 142
  • [33] MYC, BCL2, and BCL6 expression as prognostic indicators in primary central nervous system lymphoma: A systematic review and meta-analysis
    Ge, Le
    Lu, Shan
    Xu, Lixia
    Yan, Hua
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 208
  • [34] CELL OF ORIGIN ASSIGNMENT USING IMMUNOHISTOCHEMISTRY IS INFLUENCED BY BCL-2 EXPRESSION IN DLBCL PATIENTS TREATED WITH CHEMO-IMMUNOTHERAPY
    Yassin, R.
    Shieban, S.
    Pasha, T.
    Gmati, G.
    Salama, H.
    Abuelgasim, K.
    Al-Zahrani, M.
    Hejazi, A.
    Ahmed, A.
    Damlaj, M.
    HAEMATOLOGICA, 2017, 102 : 824 - 824
  • [35] Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"
    McPhail, Ellen D.
    Maurer, Matthew J.
    Ketterling, Rhett P.
    Macon, William R.
    Feldman, Andrew L.
    Kurtin, Paul J.
    Witzig, Thomas E.
    Vaidya, Rakhee
    Habermann, Thomas M.
    BLOOD, 2016, 128 (22)
  • [36] Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
    Menguy, Sarah
    Frison, Eric
    Prochazkova-Carlotti, Martina
    Dalle, Stephane
    Dereure, Olivier
    Boulinguez, Serge
    Dalac, Sophie
    Machet, Laurent
    Ram-Wolff, Caroline
    Verneuil, Laurence
    Gros, Audrey
    Vergier, Beatrice
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    Pham-Ledard, Anne
    MODERN PATHOLOGY, 2018, 31 (08) : 1332 - 1342
  • [37] Double-hit and dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
    Menguy, Sarah
    Frison, Eric
    Prochazkova-Carlotti, Martina
    Dalle, Stephane
    Dereure, Olivier
    Boulinguez, Serge
    Dalac, Sophie
    Machet, Laurent
    Ram-Wolff, Caroline
    Verneuil, Laurence
    Gros, Audrey
    Vergier, Beatrice
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    Pham-Ledard, Anne
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S20 - S20
  • [38] Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma
    Schneider, Kelli M. Clark
    Banks, Peter M.
    Collie, Angela M. B.
    Lanigan, Christopher P.
    Manilich, Elena
    Durkin, Lisa M.
    Hill, Brian T.
    Hsi, Eric D.
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1640 - 1648
  • [39] Outcomes by BCL2 and MYC expression and rearrangements in untreated diffuse large B-cell lymphoma (DLBCL) from the POLARIX trial.
    Morschhauser, Franck
    Jiang, Yanwen
    Jardin, Fabrice
    Herrera, Alex Francisco
    Sehn, Laurie Helen
    Herbaux, Charles
    Flowers, Christopher
    Phillips, Tycel Jovelle
    Guillermo, Armando Lopez
    Diefenbach, Catherine S. Magid
    Gregory, Gareth
    Kim, Austin Injae
    Barbui, Anna Maria
    Balasubramanian, Sandhya
    Harris, Will
    Hirata, Jamie
    Paulson, Joseph N.
    Lee, Calvin
    Lenz, Georg
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMAS TREATED WITH RITUXIMAB - CHOP: DEFINITION AND VALIDATION OF A PROGNOSTIC SCORE MODEL BASED ON MYC, BCL2 AND BCL6 EXPRESSION IN IMMUNOHISTOCHEMISTRY
    Castellino, A.
    Botto, B.
    Riccomagno, P.
    Chiappella, A.
    Novo, M.
    Zattera, L.
    Cavallo, F.
    Ghione, P.
    Evangelista, A.
    Ciochetto, C.
    Ciccone, G.
    Scalzo, M. S.
    Chiarle, R.
    Novero, D.
    Vitolo, U.
    HAEMATOLOGICA, 2015, 100 : 95 - 96
12345